文献速递脑血管病

急性缺血性卒中合并新诊断或已知活动性癌症患者的临床与人口学特征、机制及结局

Clinical and Demographic Characteristics, Mechanisms, and Outcomes in Patients With Acute Ischemic Stroke and Newly Diagnosed or Known Active Cancer.
PubMed 文献 · Neurology · 2023-04-24

基于洛桑急性卒中登记与分析注册研究2003—2021年数据,在6686例急性缺血性卒中患者中,362例(5.4%)合并活动性癌症,其中102例(1.5%)为新诊断癌症。新诊断癌症患者较已知活动性癌症患者卒中前残疾更少、既往卒中/短暂性脑缺血发作更少,但12个月死亡风险更高(HR 2.11,95%CI 1.38-3.21),复发卒中风险相似(调整HR 1.27,95%CI 0.67-2.43)。

要点

  • 急性缺血性卒中患者中活动性癌症占5.4%,其中新诊断癌症占1.5%。
  • 新诊断癌症患者较已知活动性癌症患者卒中前残疾更少(aOR 0.62,95%CI 0.44-0.86)。
  • 新诊断癌症患者12个月死亡风险高于已知活动性癌症患者(HR 2.11,95%CI 1.38-3.21)。

核心结论

  • 在近20年的机构注册研究中,5.4%的急性缺血性卒中患者合并活动性癌症,其中四分之一在索引卒中住院期间或之后12个月内诊断。
  • 新诊断癌症患者残疾和既往脑血管病更少,但1年后续死亡风险高于已知活动性癌症患者。

研究设计与样本

  • 使用洛桑急性卒中登记与分析注册研究2003—2021年数据,比较已知活动性癌症患者与新诊断癌症患者(卒中住院期间或随后12个月内发现癌症)。
  • 排除非活动性癌症及无癌症史患者,共纳入6686例急性缺血性卒中患者。
  • 采用多变量回归分析比较组间结局,并调整重要预后变量。

主要发现

  • 6686例急性缺血性卒中患者中,362例(5.4%)合并活动性癌症,其中102例(1.5%)为新诊断癌症。
  • 胃肠道和泌尿生殖系统癌症是最常见的癌症类型。
  • 所有活动性癌症患者中,152例(42.5%)的急性缺血性卒中归类为癌症相关,其中近半数归因于高凝状态。
  • 新诊断癌症患者较已知活动性癌症患者卒中前残疾更少(aOR 0.62,95%CI 0.44-0.86),既往卒中/短暂性脑缺血发作事件更少(aOR 0.43,95%CI 0.21-0.88)。
  • 3个月改良Rankin量表评分在癌症组间相似(aOR 1.27,95%CI 0.65-2.49),主要由新诊断脑转移(aOR 7.22,95%CI 1.49-43.17)和转移性癌症(aOR 2.19,95%CI 1.22-3.97)驱动。

关键数值与推荐

  • 12个月死亡风险:新诊断癌症患者 vs 已知活动性癌症患者 HR 2.11(95%CI 1.38-3.21)。
  • 12个月复发卒中风险:新诊断癌症患者 vs 已知活动性癌症患者 调整HR 1.27(95%CI 0.67-2.43)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Patients with a new diagnosis of cancer carry an increased risk of acute ischemic stroke (AIS), and this risk varies depending on age, cancer type, stage, and time from diagnosis. Whether patients with AIS with a new diagnosis of neoplasm represent a distinct subset from those with a previously known active malignancy remains unclear. We aimed to estimate the rate of stroke in patients with newly diagnosed cancer (NC) and previously known active cancer (KC) and to compare the demographic and clinical features, stroke mechanisms, and long-term outcomes between groups. METHODS: Using 2003-2021 data from the Acute STroke Registry and Analysis of Lausanne registry, we compared patients with KC with patients with NC (cancer identified during AIS hospitalization or within the following 12 months). Patients with inactive and no history of cancer were excluded. Outcomes were the modified Rankin scale (mRS) score at 3 months and mortality and recurrent stroke at 12 months. We used multivariable regression analyses to compare outcomes between groups while adjusting for important prognostic variables. RESULTS: Among 6,686 patients with AIS, 362 (5.4%) had active cancer (AC), including 102 (1.5%) with NC. Gastrointestinal and genitourinary cancers were the most frequent cancer types. Among all patients with AC, 152 (42.5%) AISs were classified as cancer related, with nearly half of these cases attributed to hypercoagulability. In multivariable analysis, patients with NC had less prestroke disability (adjusted odds ratio [aOR] 0.62, 95% CI 0.44-0.86) and fewer prior stroke/transient ischemic attack events (aOR 0.43, 95% CI 0.21-0.88) than patients with KC. Three-month mRS scores were similar between cancer groups (aOR 1.27, 95% CI 0.65-2.49) and were predominantly driven by the presence of newly diagnosed brain metastases (aOR 7.22, 95% CI 1.49-43.17) and metastatic cancer (aOR 2.19, 95% CI 1.22-3.97). At 12 months, mortality risk was higher in patients with NC vs patients with KC (hazard ratio [HR] 2.11, 95% CI 1.38-3.21), while recurrent stroke risk was similar between groups (adjusted HR 1.27, 95% CI 0.67-2.43). DISCUSSION: In a comprehensive institutional registry spanning nearly 2 decades, 5.4% of patients with AIS had AC, a quarter of which were diagnosed during or within 12 months after the index stroke hospitalization. Patients with NC had less disability and prior cerebrovascular disease, but a higher 1-year risk of subsequent death than patients with KC.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Costamagna G, Hottinger A, Milionis H, et al. Clinical and Demographic Characteristics, Mechanisms, and Outcomes in Patients With Acute Ischemic Stroke and Newly Diagnosed or Known Active Cancer. Neurology. 2023. PMID: 37094994. doi:10.1212/WNL.0000000000207341

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。